Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Original Research
Nonhomologous end joining key factor XLF enhances both 5-florouracil and oxaliplatin resistance in colorectal cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,067 | Dovepress* | 4,614+ | 894 | 5,508 | |
| PubMed Central* | 453 | 133 | 586 | ||
| Totals | 5,067 | 1,027 | 6,094 | ||
| *Since 20 March 2019 | |||||
View citations on PubMed Central and Google Scholar